Walleye Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Walleye Capital's XENE Position: Q3 2026 in Review
Walleye Capital sold out of Xenon Pharmaceuticals (XENE) in Q3 2026, closing a stake of 76,955 shares — an estimated $4.65M sold.
Walleye Capital first reported a position in XENE in Q3 2018 and held it in 14 quarters. The position peaked at $8.7M in Q4 2024. 285 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- Walleye Capital reported no remaining Xenon Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Walleye Capital sold 76,955 Xenon Pharmaceuticals shares in Q3 2026, an estimated $4.65M.
- Walleye Capital first reported a position in Xenon Pharmaceuticals in Q3 2018 and held it in 14 quarters.
- Walleye Capital's Xenon Pharmaceuticals position peaked at $8.7M in Q4 2024.
- 285 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.